Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noah D Peyser

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Nature|January 5, 2017
Cancer genomics: Spot the differenceNoah D Peyser, Jennifer R Grandis
Oncotargets and Therapy|August 13, 2013
Critical analysis of the potential for targeting STAT3 in human malignancyNoah D Peyser, Jennifer R Grandis
Pharmacogenomics|October 24, 2014
Genetic mutations in head and neck cancer: utilizing existing treatmentsNoah D Peyser, Jennifer R Grandis
Pharmacology & Therapeutics|November 28, 2013
Integration of molecular targeted therapy with radiation in head and neck cancerYu Du, Noah D Peyser, Jennifer R Grandis
Contemporary Clinical Trials|February 20, 2022
Digital platforms for clinical trials: The Eureka experienceNoah D Peyser, Gregory M Marcus, Alexis L Beatty, et al.
Cancers|February 15, 2022
NSAIDs Overcome <i>PIK3CA</i> Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical ModelsHua Li, Noah D Peyser, Yan Zeng, et al.
Plos One|August 13, 2015
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck CancerNoah D Peyser, Yu Du, Hua Li, et al.
Plos One|November 18, 2016
Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck CancerNoah D Peyser, Kelsey Pendleton, William E Gooding, et al.
International Journal of General Medicine|April 1, 2021
Characteristics and Behaviors Associated with Prevalent SARS-CoV-2 InfectionSidney Aung, Eric Vittinghoff, Gregory Nah, et al.
JMIR Research Protocols|July 26, 2021
The COVID-19 Citizen Science Study: Protocol for a Longitudinal Digital Health Cohort StudyAlexis L Beatty, Noah D Peyser, Xochitl E Butcher, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Nature|January 5, 2017
Cancer genomics: Spot the differenceNoah D Peyser, Jennifer R Grandis
Oncotargets and Therapy|August 13, 2013
Critical analysis of the potential for targeting STAT3 in human malignancyNoah D Peyser, Jennifer R Grandis
Pharmacogenomics|October 24, 2014
Genetic mutations in head and neck cancer: utilizing existing treatmentsNoah D Peyser, Jennifer R Grandis
Pharmacology & Therapeutics|November 28, 2013
Integration of molecular targeted therapy with radiation in head and neck cancerYu Du, Noah D Peyser, Jennifer R Grandis
Contemporary Clinical Trials|February 20, 2022
Digital platforms for clinical trials: The Eureka experienceNoah D Peyser, Gregory M Marcus, Alexis L Beatty, et al.
Cancers|February 15, 2022
NSAIDs Overcome <i>PIK3CA</i> Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical ModelsHua Li, Noah D Peyser, Yan Zeng, et al.
Plos One|August 13, 2015
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck CancerNoah D Peyser, Yu Du, Hua Li, et al.
Plos One|November 18, 2016
Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck CancerNoah D Peyser, Kelsey Pendleton, William E Gooding, et al.
International Journal of General Medicine|April 1, 2021
Characteristics and Behaviors Associated with Prevalent SARS-CoV-2 InfectionSidney Aung, Eric Vittinghoff, Gregory Nah, et al.
JMIR Research Protocols|July 26, 2021
The COVID-19 Citizen Science Study: Protocol for a Longitudinal Digital Health Cohort StudyAlexis L Beatty, Noah D Peyser, Xochitl E Butcher, et al.
Pageof 3